Archive - August 2021
AZ’s new rare disease unit wins in Wilson disease
Merck’s Keytruda gains two more approvals in Japan
AstraZeneca’s Forxiga approved in Japan for the treatment of CKD
MHRA authorises UCB’s Bimzelx via post-Brexit licensing pathway
8 Surprising Wine Health Benefits And Brands You Should Be Drinking
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
ICR cancer drug NXP800 to enter Phase I trials
NICE ‘no’ for Janssen’s Darzalex combo